MPG.eBooks - Search Results

161

Pharmacoeconomic review report: Guselkumab (Tremfya) (Janssen Inc.)

Published 2018

CADTH

Subjects: “...Antibodies, Monoclonal / economics...”

Read Now

162

Eltrombopag for the treatment of aplastic anemia : a review of clinical and cost-effectiveness

by Ho, Chuong, Visintini, Sarah
Published 2018

CADTH

Subjects: “...Thrombopoietin / economics...”

Read Now

163

Pharmacoeconomic review report: Ozenoxacin 1% cream (Ozanex), (Ferrer internacional, S.A.) : indication : the topical treatment of impetigo in patients aged two months and older

Published 2018

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Quinolones / economics...”

Read Now

164

Pharmacoeconomic review report: Dupilumab (Dupixent) (Sanofi-Aventis Canada Inc.)

Published 2018

CADTH

Subjects: “...Antibodies, Monoclonal / economics...”

Read Now

165

Periodic dental examinations for oral health : a review of clinical effectiveness, cost effectiveness, and guidelines

Published 2014

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Preventive Dentistry / economics...”

Read Now

166

CADTH Canadian Drug Expert Committee recommendation: Dupilumab (Dupixent -- Sanofi-Aventis Canada Inc.) : indication: atopic dermatitis

Published 2018

CADTH

Subjects: “...Antibodies, Monoclonal / economics...”

Read Now

167

Pharmacoeconomic review report: Dupilumab (Dupixent) (Sanofi-Aventis Canada Inc.)

Published 2018

CADTH

Subjects: “...Antibodies, Monoclonal / economics...”

Read Now

168

Periodic dental examinations for oral health : a review of clinical effectiveness, cost effectiveness, and guidelines

Published 2014

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Preventive Dentistry / economics...”

Read Now

169

Switching from innovator to biosimilar (subsequent entry) infliximab : an updated review of the clinical effectiveness, cost-effectiveness, and guidelines

Published 2017

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Biosimilar Pharmaceuticals / economics...”

Read Now

170

Clinical review report: Inotersen (Tegsedi) (Akcea therapeutics, inc.) : indication: stage I or II polyneuropathy in adults with hereditary transthyretin-mediated amyloidosis (hATT...

Published 2020

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Oligonucleotides, Antisense / economics...”

Read Now

171

Pharmacoeconomic review report: Ertugliflozin (Steglatro) (Merck Canada Inc.) : indication : type 2 diabetes mellitus

Published 2019

CADTH

Subjects: “...Bridged Bicyclo Compounds, Heterocyclic / economics...”

Read Now

172

Pharmacoeconomic review report: Ertugliflozin (Steglatro) (Merck Canada Inc.) : indication : type 2 diabetes mellitus

Published 2019

CADTH

Subjects: “...Bridged Bicyclo Compounds, Heterocyclic / economics...”

Read Now

173

Early biologic treatment versus conventional treatment for the management of Crohn's disease : a review of comparative clinical effectiveness and cost-effectiveness

by Thompson, Wade, Argáez, Charlene
Published 2019

CADTH

Subjects: “...Tumor Necrosis Factor Inhibitors / economics...”

Read Now

174

Pharmacoeconomic review report: Mifepristone and misoprostol (Mifegymiso)

Published 2017

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Drug Therapy, Combination / economics...”

Read Now

175

Drugs for chronic hepatitis C infection : cost-effectiveness analysis

by Wong, William, Krahn, Murray, Lee, Karen M., Singh, Sumeet
Published 2016

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Antiviral Agents / economics...”

Read Now

176

Disposable, non-sterile gloves for minor surgical procedures : a review of clinical evidence

by Ho, Chuong, Adams, Alison
Published 2017

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Gloves, Surgical / economics...”

Read Now

177

Deep brain stimulation for Parkinson's disease : a review of clinical effectiveness, cost-effectiveness, and guidelines

by Lachance, Chantelle, Spry, Carolyn, MacDougall, Danielle
Published 2018

CADTH

Subjects: “...Deep Brain Stimulation / economics...”

Read Now

178

Pharmacoeconomic review report: Inotersen (Tegsedi) (Akcea Therapeutics, Inc.) : indication : stage I or II polyneuropathy in adults with hereditary transthyretin-mediated amyloido...

Published 2020

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Oligonucleotides, Antisense / economics...”

Read Now

179

Pharmacoeconomic review report: Upadacitinib (Rinvoq) (AbbVie) : indication: for the treatment of adults with moderately to severely active rheumatoid arthritis who have had an ina...

Published 2020

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Janus Kinase Inhibitors / economics...”

Read Now

180

Pharmacoeconomic review report: Benralizumab (Fasenra) (AstraZeneca Canada Inc.) : indication : an add-on maintenance treatment of adult patients with severe eosinophilic asthma

Published 2018

CADTH

Subjects: “...Anti-Asthmatic Agents / economics...”

Narrow Search